· Op-Ed/Commentary
COVID-19InequalityIntellectual Property New York Times Does Public Relations Work for the Pharmaceutical IndustryDean Baker / March 21, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property Thomas Cueni, Director General of the International Pharma Trade Association, Calls Bill Gates a MoronDean Baker / March 17, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryInequalityIntellectual Property The New York Times Has not Heard of China’s (or Russia’s) VaccinesDean Baker / March 04, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property To Prevent the Resurgence of the Pandemic, Can We Talk About Open-Source Research?Dean Baker / February 26, 2021
· Article
COVID-19EducationInequalityUnited States Pandemic-Related Drop in College Enrollment Reveals Inequities in Access to Higher EdSepideh Jessica Vasseghi / February 16, 2021
· Op-Ed/Commentary
COVID-19GovernmentIntellectual PropertyUnited States Want to Reverse Inequality? Change Intellectual Property RulesDean Baker / THE NATION / February 08, 2021
· Article
COVID-19EnvironmentEuropeIMFWorld Great.com Interviews CEPR about Climate Change, Social Security, and a Global Response to COVIDDan Beeton / February 04, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property Should People Who Want to Save the World from the Pandemic Be Demanding We Pay China to Produce Billions of Vaccine Doses?Dean Baker / February 04, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property Dealing with a Pandemic as If Human Lives MatteredDean Baker / February 02, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryInequalityIntellectual Property The Coronavirus Vaccine Fail and International ElitesDean Baker / January 25, 2021